Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

544 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Risk assessment of disease recurrence in early breast cancer: A serum metabolomic study focused on elderly patients.
Risi E, Lisanti C, Vignoli A, Biagioni C, Paderi A, Cappadona S, Monte FD, Moretti E, Sanna G, Livraghi L, Malorni L, Benelli M, Puglisi F, Luchinat C, Tenori L, Biganzoli L. Risi E, et al. Among authors: moretti e. Transl Oncol. 2023 Jan;27:101585. doi: 10.1016/j.tranon.2022.101585. Epub 2022 Nov 17. Transl Oncol. 2023. PMID: 36403505 Free PMC article.
Taxanes in the elderly: can we gain as much and be less toxic?
Biganzoli L, Licitra S, Moretti E, Pestrin M, Zafarana E, Di Leo A. Biganzoli L, et al. Among authors: moretti e. Crit Rev Oncol Hematol. 2009 Jun;70(3):262-71. doi: 10.1016/j.critrevonc.2008.07.017. Epub 2008 Aug 30. Crit Rev Oncol Hematol. 2009. PMID: 18762431 Review.
Adjuvant chemotherapy: which patient? What regimen?
Turner N, Biganzoli L, Malorni L, Migliaccio I, Moretti E, Pestrin M, Sanna G, Siclari O, Di Leo A. Turner N, et al. Among authors: moretti e. Am Soc Clin Oncol Educ Book. 2013:3-8. doi: 10.14694/EdBook_AM.2013.33.3. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714442 Free article.
The continued evidence from overviews: what is the clinical utility?
Turner N, Biganzoli L, Malorni L, Migliaccio I, Moretti E, Pestrin M, Sanna G, Siclari O, Di Leo A. Turner N, et al. Among authors: moretti e. Breast. 2013 Aug;22 Suppl 2:S8-11. doi: 10.1016/j.breast.2013.07.002. Breast. 2013. PMID: 24074798 Free article. Review.
Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial.
Malorni L, Curigliano G, Minisini AM, Cinieri S, Tondini CA, D'Hollander K, Arpino G, Bernardo A, Martignetti A, Criscitiello C, Puglisi F, Pestrin M, Sanna G, Moretti E, Risi E, Biagioni C, McCartney A, Boni L, Buyse M, Migliaccio I, Biganzoli L, Di Leo A. Malorni L, et al. Among authors: moretti e. Ann Oncol. 2018 Aug 1;29(8):1748-1754. doi: 10.1093/annonc/mdy214. Ann Oncol. 2018. PMID: 29893790 Free PMC article. Clinical Trial.
The role of abemaciclib in treatment of advanced breast cancer.
McCartney A, Moretti E, Sanna G, Pestrin M, Risi E, Malorni L, Biganzoli L, Di Leo A. McCartney A, et al. Among authors: moretti e. Ther Adv Med Oncol. 2018 May 31;10:1758835918776925. doi: 10.1177/1758835918776925. eCollection 2018. Ther Adv Med Oncol. 2018. PMID: 29899762 Free PMC article. Review.
544 results